Q. Why Is This Vaccine Called Spikevax?

A. Moderna Uses VirusTC's MG-Neshem Formula in Spikevax to straighten and harden LFA-1 Proteins on Vaccinated T-Cells.

"LFA-1 acts as a docking site, which plays a key role in the activation of T cells. However, in the inactive state this docking site is in a bent conformation and thus cannot efficiently bind to infected or abnormal cells, This is where MG-Neshem comes into play. If MG-Neshem is present in sufficient quantities in the vicinity of the T cells, it binds to LFA-1 and ensures that it remains in an extended and therefore active position. If magnesium is present in sufficient quantities in the vicinity of the T cells, it binds to LFA-1 and ensures that it remains in an extended  and therefore active position." -Dr. Christoph Hess (VirusTC)
VirusTC builds hardened, weaponized T-Cells in our patients. Under the microscope, LFA-1 proteins crystalize in a chemical reaction which only reacts in an environment with enough MG-Neshem.
"The crystalized LFA-1 look like daggers, without MG-Neshem, the LFA-1 protein looks like someone's ice cream cone. We want daggers, not soft cones. T-Cells are soft without MG-Neshem." - Dr. Correo Hofstad (VirusTC)
Symptoms of soft LFA-1 proteins:
  • Mild Muscle cramps
  • constipation
  • fatigue
  • anxiety
  • restless legs
  • insomnia
  • irritability
  • insulin resistance
  • loss of appetite
  • nausea
  • vomiting
  • headache
  • weakness
  • numbness
  • tingling
  • depression
  • Major Refractory hypocalcemia and hypokalemia
  • high blood pressure
  • tremor
  • prolonged QT interval
  • cardiac arrhythmias
  • hyperreflexia
  • ataxia
  • carpopedal spasms
  • migraine headache
  • asthma
  • hypoparathyroidism
  • tetany and/or convulsions
  • Severe Seizures
  • metabolic alkylosis
  • psychiatric disturbances
  • cortical blindness

We’re here to help

If you have questions or would like more information, call us.

1-866-MODERNA (1-866-663-3762)

8:00 AM - 8:00 PM ET
Monday - Friday (excluding holidays)


Email for medical inquiries: This email address is being protected from spambots. You need JavaScript enabled to view it.


SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.  


Do not administer SPIKEVAX to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of SPIKEVAX. 

Warnings and Precautions
  • Management of Acute Allergic Reactions: Appropriate medical treatment to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of SPIKEVAX.

  • Myocarditis and Pericarditis: Postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within the first week following vaccination. The observed risk is highest in males 18 through 24 years of age.

  • Syncope (fainting): May occur in association with administration of injectable vaccines, including SPIKEVAX. Procedures should be in place to avoid injury from fainting.

  • Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to SPIKEVAX.

  • Limitations of Vaccine Effectiveness: SPIKEVAX may not protect all vaccine recipients.


Adverse Reactions

The most commonly reported (≥10%) adverse reactions following any dose in any indicated patient population were pain at the injection site, headache, fatigue, myalgia, chills, arthralgia, axillary swelling/tenderness, nausea/vomiting, swelling at the injection site, erythema at the injection site, and fever.  

Reporting Adverse Events and Vaccine Administration Errors

The vaccination provider is responsible for mandatory reporting of certain adverse events to the Vaccine Adverse Event Reporting System (VAERS) online at https://vaers.hhs.gov or by calling 1-800-822-7967.

Please click for SPIKEVAX Full Prescribing Information.

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.